跳转至内容
Merck
CN

EHU126551

MISSION® esiRNA

targeting human CENPBD1, RP11-566K11.5

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

NACRES:
NA.51
UNSPSC Code:
41105324
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


description

Powered by Eupheria Biotech

Quality Level

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

TTTGGCCTGAGTGTGTTCAGGCCCAGCGTTTTTCCCAGGCAGATAACATTGCACAGCTTCAAAAAAACATTGTGACCCTTGCCAGAAATGTGGCCTTTGAAGAGGTTGCTGAGGCTGCTGTGGACCAGTTGCTGCAGTCCCATGAAGAAGATCTCTCAAATGAGGAACTGATGCGGCTGGAACAGGAGCTGGCAGTGGGGGAGGAGGAGAGGGAAGATGGTCC

Ensembl | human accession no.

NCBI accession no.

shipped in

ambient

storage temp.

−20°C

Gene Information

General description

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany


存储类别

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Wen-Tsan Weng et al.
International journal of molecular sciences, 19(12) (2018-12-06)
α-melanocyte-stimulating hormone (α-MSH) has been characterized as a novel angiogenesis inhibitor. The homeostasis of nitric oxide (NO) plays an important role in neovascularization. However, it remains unclear whether α-MSH mitigates angiogenesis through modulation of NO and its signaling pathway. The



全球贸易项目编号

货号GTIN
EHU126551-20UG04061831359794
EHU126551-50UG04061828358595